leadf
logo-loader
viewValeo Pharma Inc.

Valeo Pharma closes oversubscribed bought deal bringing in 6.9 million to treasury

Valeo Pharma (CSE: VPH) CEO Steve Saviuk joined Steve Darling from Proactive Vancouver with news the company has closed its previously announced bought deal offering and along with the exercise in full of the Underwriters’ over-allotment option of 750,000 additional Units, the company has topped up the treasury with 6.9 million dollars.

Saviuk shares with Proactive where the capital is expected to be deployed and he also shares his thoughts on the approval of the immune system boosting product Hesperco from Health Canada. 

Quick facts: Valeo Pharma Inc.

Price: 1.17 CAD

CSE:VPH
Market: CSE
Market Cap: $66.29 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Zinc8 Energy Solutions wins major company changing award from New York Dept...

Zinc8 Energy Solutions (CSE: ZAIR-OTC PINK: MGXRF) CEO Ron MacDonald joined Steve Darling from Proactive Vancouver with news the company has been named as the winner of a contest put on by the powerful and large New York Department of Buildings.  MacDonald explains what this means for...

31 minutes ago

2 min read